Prostate cancer clinical quality performance indicators: engagement document

Document explaining the process of, and inviting engagement on, revision of the prostate cancer QPIs.

12. References

1. Scottish Government (2008). Better Cancer Care: An Action Plan [online]. Available from:
(accessed August 2013).

2. Scottish Government (2010) Healthcare Quality Strategy for NHSScotland [online]. Available from: (accessed August 2013).

3. ACCC (2007) Association of Comprehensive Cancer Centres / Dutch Urological Association. Prostate cancer [online]. Available from:
(accessed August 2013).

4. NICE (2008). Prostate cancer: diagnosis and treatment [online]. Available from: (accessed August 2013)

5. PCRMP (2006). Prostate Cancer Risk Management Programme. Undertaking a trans-rectal ultrasound guided biopsy of the prostate [online]. Available from: (accessed August 2013).

6. EAU (2010). European Association of Urology. Guidelines on prostate cancer [online]. Available from: (accessed August 2013).

7. Royal College of Radiologists (2007). Making the best use of clinical radiology services (sixth edition) [online].

8. Wang et al (2006). Prediction of Organ-confined Prostate Cancer: Incremental Value of MR Imaging and MR Spectroscopic Imaging to Staging Nomograms. Radiology. 238(2), 597-603.

9. Wang et al (2009). Incremental value of magnetic resonance imaging in the advanced management of prostate cancer. World Journal of Radiology. 1(1), 3-14.

10. Royal College of Pathologists (2009). Dataset for histopathology reports for prostatic carcinoma (2nd edition) [online]. Available from: (accessed August 2013).

11. CCO (2008). Cancer Care Ontario. Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: surgical and pathological guidelines [online]. Available from: (accessed August 2013).

12. NHS Quality Improvement Scotland (2008). Management of Core Cancer Services Standards [online]. Available from: (accessed August 2013).

13. NICE (2015). Prostate Cancer [online]. Available from: (accessed February 2016).

14. Bul et al (2013). Active Surveillance for Low-Risk Prostate Cancer Worldwide:
The PRIAS Study. European Urology. 63 (4), 597 - 603.

15. Nice (2014): Prostate Cancer: Diagnosis and Management. Available from: (accessed March 2016)

16. Vickers AJ, Savage CJ, Hruza M, Tuerk I, Koenig P, Martinez-Pineiro L, et al.
The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study. Lancet Oncol 2009;10(5):475-80.

17. Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, et al.
The surgical learning curve for prostate cancer control after radical prostatectomy.
J Natl Cancer Inst 2007;99(15):1171-7.

18. UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database

19. JB Anderson, NC Clarke, D Gillatt, P Dasgupta, DE Neal,RS Pickard (2012).
Advice on the Development of Robotic Assisted Radical Prostatectomy in England - Prostate Cancer Advisory Group

20. Loblaw, DA, Virgo, KS, Nam, R, Somerfield, MR, Ben-Josef, E, et al. for the American Society of Clinical Oncology (2007). Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. Journal of Clinical Oncology. 25(12), 1596-605.

21. James et all (2015): Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer ( STAMPEDE):survival results from an adaptive, multiarm, multistage,platform randomised controlled trial [online]. Available from (Accessed January 2016).

22. NHS Quality Improvement Scotland (2008). Clinical Standards for the Management of Bowel Cancer [online]. Available from:
(accessed February 2016).


Back to top